Opportunity Information: Apply for PAR 18 304

The NIH SIREN Neurologic Clinical Trials funding opportunity (PAR 18-304) is a National Institutes of Health (NIH) cooperative agreement mechanism (U01) designed to support rigorous, multi-center clinical trials that address neurological emergencies. The central idea is to move time-sensitive neurologic interventions forward by testing them in real-world emergency settings where rapid decision-making, streamlined workflows, and strong coordination across multiple hospitals and EMS-linked systems are essential. Because it is a "Clinical Trial Required" announcement, applications are expected to propose an actual interventional clinical trial rather than observational work or preliminary planning alone.

Projects funded through this announcement are expected to be conducted within the NIH StrokeNet / SIREN (Strategies to Innovate EmeRgENcy Care Clinical Trials Network) infrastructure. Investigators do not operate in isolation; instead, the proposed trial is carried out in collaboration with the established SIREN Network to take advantage of its readiness for emergency research, its experienced clinical sites, and its standardized processes. Awardees work closely with two core coordinating entities: the SIREN Clinical Coordinating Center (CCC) and the SIREN Data Coordinating Center (DCC). The CCC supports practical trial execution, helping ensure the study can be implemented efficiently across many sites (for example, aligning start-up activities, operational procedures, and site activation). The DCC provides statistical leadership and data management support, which typically includes study design input, randomization approaches, data capture systems, monitoring plans, and analysis support consistent with multi-site trial standards. On the ground, SIREN hubs and their affiliated clinical sites are the places where protocols are implemented and participants are enrolled and treated, meaning the network provides the operational footprint needed for enrollment in high-acuity, emergency contexts.

The opportunity sits within NIH's health research mission and is associated with multiple CFDA numbers (93.837, 93.838, 93.839, 93.853), reflecting that neurologic emergency trials can fall under several NIH institutes or program areas depending on the condition and intervention. The activity category is Health, and the instrument type is a cooperative agreement, which typically means NIH staff will have substantial programmatic involvement compared with a traditional research project grant. In practice, that usually translates into closer federal involvement in trial oversight, milestone-driven management, and a higher expectation of coordination with network governance and common SIREN procedures.

Eligibility is intentionally broad to encourage participation from many sectors capable of leading or partnering on emergency neurologic trials. Eligible applicants include a wide range of U.S. governmental entities (state, county, city/township, special districts), independent school districts, and public housing authorities/Indian housing authorities, as well as public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), and small businesses. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), tribal governments that are not federally recognized, eligible federal agencies, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This breadth signals NIH's intent to bring diverse institutions into high-impact emergency research, including organizations serving historically underrepresented communities and regions.

Administratively, the opportunity was created on 2017-10-03 and listed an original closing date of 2021-03-05. The posted record does not specify an award ceiling or the expected number of awards, which generally means those details would need to be confirmed in the full FOA text or related NIH budget guidance for the relevant receipt dates. Overall, the program is best understood as an NIH-supported pathway for launching and running definitive, multi-site neurologic emergency clinical trials using the established SIREN Network infrastructure, with built-in coordinating and data/statistical support to increase the likelihood that complex emergency trials can be executed quickly, consistently, and at scale.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIH SIREN Neurologic Clinical Trials (U01 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.837, 93.838, 93.839, 93.853.
  • This funding opportunity was created on 2017-10-03.
  • Applicants must submit their applications by 2021-03-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 304

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Not Allowed)

Previous opportunity: Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 304

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 304) also looked into and applied for these:

Funding Opportunity
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 - Clinical Trial Not Allowed) Apply for PAR 18 402

Funding Number: PAR 18 402
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 - Clinical Trial Not Allowed) Apply for PAR 18 403

Funding Number: PAR 18 403
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Amplify Family Planning and Sexual and Reproductive Health Activity (AMPLIFY-FP)) Apply for RFI 624 18 000001

Funding Number: RFI 624 18 000001
Agency: West Africa USAID-Ghana
Category: Health
Funding Amount: $18,500,000
National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32) Apply for PAR 17 341

Funding Number: PAR 17 341
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) Apply for RFA CA 17 048

Funding Number: RFA CA 17 048
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,200,000
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 18 319

Funding Number: PAR 18 319
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) Apply for RFA CA 17 047

Funding Number: RFA CA 17 047
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional) Apply for PA 18 322

Funding Number: PA 18 322
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional) Apply for PA 18 323

Funding Number: PA 18 323
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Announcement of Anticipated Availability of Funds for Support for Expectant and Parenting Teens, Women, Fathers, and Their Families Apply for AH SP1 18 001

Funding Number: AH SP1 18 001
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $1,000,000
NHLBI Program Project Applications (P01 - Clinical Trials Optional) Apply for PAR 18 405

Funding Number: PAR 18 405
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Maintaining Immunity After Immunization (U01 - Clinical Trial Optional) Apply for RFA AI 17 034

Funding Number: RFA AI 17 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 18 329

Funding Number: PAR 18 329
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 326

Funding Number: PAR 18 326
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Immunity in the Elderly (R01) Clinical Trial Optional Apply for RFA AI 17 037

Funding Number: RFA AI 17 037
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) Apply for RFA AG 18 019

Funding Number: RFA AG 18 019
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) Apply for PAR 18 406

Funding Number: PAR 18 406
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Role of Peripheral Proteostasis on Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 020

Funding Number: RFA AG 18 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required Apply for PAR 18 407

Funding Number: PAR 18 407
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) Apply for PAR 18 410

Funding Number: PAR 18 410
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 304", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: